Abstract | PURPOSE: EXPERIMENTAL DESIGN: RESULTS: CONCLUSION: These results clearly showed that ERbeta nongenomic signaling is active in salivary gland cells and has a biological role in migration, presumably via the stimulation of ERK1/2. In future, the findings of this study might have clinical importance as several ERbeta-selective agonists are currently being available, and these could potentially be used for therapeutic targeting of ERbeta-positive salivary tumors.
|
Authors | Kazufumi Ohshiro, Suresh K Rayala, Michelle D Williams, Rakesh Kumar, Adel K El-Naggar |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 12
Issue 20 Pt 1
Pg. 5994-9
(Oct 15 2006)
ISSN: 1078-0432 [Print] United States |
PMID | 17062671
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Estrogen Receptor alpha
- Estrogen Receptor beta
- Mitogen-Activated Protein Kinases
|
Topics |
- Adenocarcinoma
(physiopathology)
- Cell Line, Tumor
- Cell Movement
- Estrogen Receptor alpha
(physiology)
- Estrogen Receptor beta
(physiology)
- Humans
- Mitogen-Activated Protein Kinases
(metabolism)
- Salivary Gland Neoplasms
(physiopathology)
- Signal Transduction
- Wound Healing
|